Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Ogawa

Showing results (1-10 of 444) with videos related to

Pageof 45
Sort By:
Internal Medicine (Tokyo, Japan)|March 10, 2004
Differences in selection criteria for antiarrhythmic drugs in Japan and the USSatoshi Ogawa
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 13, 2007
[Atrial fibrillation up to date. 2) Rhythm control and rate control--on the results of a large scale clinical trial J-RHYTHM]Satoshi Ogawa
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 6, 2003
[ORP150 (150 kDa oxygen regulated protein) suppressed neuronal cell death]Satoshi Ogawa
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 17, 2003
[Japanese and American guidelines for atrial fibrillation--difference in the standards for selecting anti-arrhythmic agents in the two countries]Satoshi Ogawa
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 3, 2002
[History of cardiology in the last 100 years: Arrhythmia]Satoshi Ogawa
Circulation Journal : Official Journal of the Japanese Circulation Society|January 10, 2003
New ECG criteria for high-risk Brugada syndromeHirotsugu Atarashi, Satoshi Ogawa,
Circulation Journal : Official Journal of the Japanese Circulation Society|November 10, 2011
Urgent statement on antithrombotic therapy of atrial fibrillationSatoshi Ogawa, Masatsugu Hori
Seikagaku. the Journal of Japanese Biochemical Society|November 30, 2006
[Neuronal cell death and stress response]Satoshi Ogawa, Osamu Hori
Journal of Electrocardiology|May 29, 2007
Bepridil produces prominent bradycardia-dependent QT prolongation in patients with structural heart diseaseTsuneaki Sadanaga, Satoshi Ogawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2007
[Atrial fibrillation--etiology, pathophysiological mechanisms, and therapy]Toshimi Kageyama, Satoshi Ogawa
Pageof 45

Showing results (1-10 of 444) with videos related to

Sort By:
Pageof 45
Internal Medicine (Tokyo, Japan)|March 10, 2004
Differences in selection criteria for antiarrhythmic drugs in Japan and the USSatoshi Ogawa
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 13, 2007
[Atrial fibrillation up to date. 2) Rhythm control and rate control--on the results of a large scale clinical trial J-RHYTHM]Satoshi Ogawa
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 6, 2003
[ORP150 (150 kDa oxygen regulated protein) suppressed neuronal cell death]Satoshi Ogawa
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 17, 2003
[Japanese and American guidelines for atrial fibrillation--difference in the standards for selecting anti-arrhythmic agents in the two countries]Satoshi Ogawa
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 3, 2002
[History of cardiology in the last 100 years: Arrhythmia]Satoshi Ogawa
Circulation Journal : Official Journal of the Japanese Circulation Society|January 10, 2003
New ECG criteria for high-risk Brugada syndromeHirotsugu Atarashi, Satoshi Ogawa,
Circulation Journal : Official Journal of the Japanese Circulation Society|November 10, 2011
Urgent statement on antithrombotic therapy of atrial fibrillationSatoshi Ogawa, Masatsugu Hori
Seikagaku. the Journal of Japanese Biochemical Society|November 30, 2006
[Neuronal cell death and stress response]Satoshi Ogawa, Osamu Hori
Journal of Electrocardiology|May 29, 2007
Bepridil produces prominent bradycardia-dependent QT prolongation in patients with structural heart diseaseTsuneaki Sadanaga, Satoshi Ogawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 16, 2007
[Atrial fibrillation--etiology, pathophysiological mechanisms, and therapy]Toshimi Kageyama, Satoshi Ogawa
Pageof 45